{
    "title": "New drug for cervical cancer patients approved for use in NHS in Scotland",
    "url": "https://www.dailymail.co.uk/wires/pa/article-11745537/New-drug-cervical-cancer-patients-approved-use-NHS-Scotland.html",
    "date": "2023-02-13",
    "keywords": [
        "cancer",
        "treatment",
        "time",
        "uk",
        "decision",
        "scotland",
        "part",
        "smc",
        "use",
        "drug",
        "pembrolizumab",
        "disease",
        "process",
        "access",
        "nhs",
        "consortium",
        "pace",
        "head",
        "msd",
        "year",
        "samantha",
        "trust",
        "care",
        "nivolumab",
        "bladder",
        "condition",
        "hypophosphataemia",
        "company",
        "keytruda",
        "approval",
        "patient",
        "help",
        "end",
        "life",
        "morbidity",
        "diagnosis",
        "lynne",
        "cameronpa",
        "deprivation",
        "age",
        "need",
        "option",
        "executive",
        "dixon",
        "area",
        "wealth",
        "postcode",
        "lottery",
        "institute",
        "health",
        "excellence",
        "nice",
        "light",
        "optivo",
        "form",
        "bone",
        "risk",
        "osteoporosis",
        "burosumab",
        "cost",
        "clarity",
        "chairman",
        "mark",
        "macgregor",
        "committee",
        "progression",
        "evidence",
        "pain",
        "fatigue",
        "relative",
        "opportunity",
        "certainty"
    ],
    "category": [
        "wires",
        "pa"
    ]
}